Did Novo Nordisk executive faint in Oval Office? Company clarifies amid buzz about Gordon Findlay

Man Faints in Oval Office During Press Conference

A press conference at the White House on Thursday was suddenly interrupted when a man fainted in the Oval Office. President Donald Trump was announcing a deal with pharmaceutical companies to reduce the cost of obesity drugs at the time.

Incident and Public Reaction

The video of the man collapsing was widely shared online. Independent journalist Eric Daugherty posted the footage, stating:

“A man just passed out during President Trump’s Oval Office announcement. Oz SPRUNG into action and assisted him.”
“Pray for him.”

Many viewers offered prayers for the man’s well-being as the live feed ended abruptly.

Misidentification and Company Response

The man was initially identified as Gordon Findlay and was claimed by some to be a Novo Nordisk executive. An X account posted:

“BREAKING: Novo Nordisk executive Gordon Findlay collapses during Trump's announcement in Oval Office, announcement suspended.”

However, Novo Nordisk clarified the facts:

“CEO Mike Doustdar and EVP, US Operations, Dave Moore were the only two Novo Nordisk representatives in the Oval Office. We hope the gentleman who suffered a medical incident today is okay.”

Further Clarification from the White House

White House Press Secretary Karoline Leavitt explained the situation during the announcement:

“During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted.”

Summary

The man who fainted in the Oval Office during President Trump’s announcement was not affiliated with Novo Nordisk, and the reason for his collapse has not been publicly disclosed.

Author’s summary: A man fainted during President Trump’s Oval Office announcement about obesity drug pricing, initially misidentified but later confirmed unrelated to Novo Nordisk.

more

Hindustan Times Hindustan Times — 2025-11-06